author-photo

Philip Dube

Rensselaer Polytechnic Institute

6

Papers

19

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Ruxolitinib, a JAK1/JAK2 selective inhibitor, ameliorates acute and chronic steroid-refractory GvHD mouse models.

2021 Immunotherapy
Show All
- Source
- Cite
- Save
Citations (0)
Dietary Emulsifiers Directly Impact Adherent-Invasive E. coli Gene Expression to Drive Chronic Intestinal Inflammation.

2020 Cell Reports
Show All
- Source
- Cite
- Save
Citations (17)
189 A clear increase in TILs and modest tumor growth inhibition by pembrolizumab in prostate cancer tumors growing in bone of CD34+ engrafted NOG mice

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Abstract B143: Establishment of primary tumor models of TNBC and ER+/HER2- breast cancer in humanized mice and validation of pembrolizumab efficacy

2019 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)